SomnoMed Limited (ASX:SOM)

SomnoMed Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	118.5	111.49	91.65	83.62	72.58	62.71
Revenue Growth (YoY)	18.21%	21.65%	9.61%	15.20%	15.75%	9.44%
Cost of Revenue	47.63	44.76	36.52	31.69	28.3	24.96
Gross Profit	70.87	66.73	55.13	51.92	44.28	37.74
Selling, General & Admin	61.31	59.35	57.61	49.37	43.28	34.52
Other Operating Expenses	-	-	-	-	-	0.2
Operating Expenses	69.79	67.04	63.46	55.53	48.41	38.6
Operating Income	1.08	-0.31	-8.33	-3.6	-4.13	-0.85
Interest Expense	-0.49	-0.4	-2.14	-2.63	-0.38	-0.47
Interest & Investment Income	0.04	0.02	0.03	0	0	0
Currency Exchange Gain (Loss)	-0.79	-0.08	0.2	-0.35	0.73	-0.07
Other Non Operating Income (Expenses)	0.01	0.01	-1.03	-0.46	0	-
EBT Excluding Unusual Items	-0.16	-0.76	-11.27	-7.05	-3.78	-1.39
Other Unusual Items	-	-	-	-	0.29	0.66
Pretax Income	-0.16	-0.76	-11.27	-7.05	-3.5	-0.73
Income Tax Expense	2.4	2.69	0.97	0.82	0.93	0.35
Earnings From Continuing Operations	-2.56	-3.46	-12.24	-7.87	-4.43	-1.08
Earnings From Discontinued Operations	-	-	-	-0.13	-0.01	-0.11
Net Income to Company	-2.56	-3.46	-12.24	-8	-4.44	-1.19
Net Income	-2.56	-3.46	-12.24	-8	-4.44	-1.19
Net Income to Common	-2.56	-3.46	-12.24	-8	-4.44	-1.19
Shares Outstanding (Basic)	216	212	121	79	79	78
Shares Outstanding (Diluted)	216	212	121	79	79	78
Shares Change (YoY)	19.96%	75.54%	53.66%	0.01%	0.16%	24.22%
EPS (Basic)	-0.01	-0.02	-0.10	-0.10	-0.06	-0.02
EPS (Diluted)	-0.01	-0.02	-0.10	-0.10	-0.06	-0.02
Free Cash Flow	3.71	5.36	-7.42	-7.02	0.85	0.55
Free Cash Flow Per Share	0.02	0.03	-0.06	-0.09	0.01	0.01
Gross Margin	59.81%	59.85%	60.15%	62.09%	61.01%	60.19%
Operating Margin	0.91%	-0.28%	-9.09%	-4.31%	-5.69%	-1.36%
Profit Margin	-2.16%	-3.10%	-13.36%	-9.57%	-6.11%	-1.90%
Free Cash Flow Margin	3.13%	4.81%	-8.10%	-8.39%	1.17%	0.88%
EBITDA	3.68	1.58	-6.5	-1.98	-2.7	0.63
EBITDA Margin	3.10%	1.42%	-7.09%	-2.37%	-3.72%	1.00%
D&A For EBITDA	2.59	1.89	1.83	1.62	1.43	1.48
EBIT	1.08	-0.31	-8.33	-3.6	-4.13	-0.85
EBIT Margin	0.91%	-0.28%	-9.09%	-4.31%	-5.69%	-1.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.